In this article, we will discuss Durvalumab (Dosage Modifications-3). So, let’s get started.
Hepatitis with no tumor involvement of the liver
- ALT or AST increases to more than 3 and up to 8 times the ULN or total bilirubin increases to more than 1.5 and up to 3 times ULN – Withhold
- ALT or AST increases to more than 8 times ULN or total bilirubin increases to more than 3 times the ULN – Permanently discontinue